TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.230

+0.9%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 9wald9 who wrote (425)	1/12/2005 10:32:20 AM
From: Mike McFarland	Read Replies (1) of 557

Targeted Genetics jumps on collaboration deal By Val Brickates Kennedy, CBS.MarketWatch.com BOSTON (CBS.MW) -- Targeted Genetics shares rose as much as 12 percent Tuesday on news that the company had signed a collaboration agreement to develop gene therapies to treat heart disease. Shares of Seattle-based Targeted Genetics (TGEN: news, chart, profile), a tiny gene therapy developer, closed up 6.98 percent at $1.67. I do not see the shares trading that high, in fact they seem to be trading down. finance.yahoo.com currently $1.53 by $1.54 The street does not see this as bullish, although in the wake of stem cell speculation lately, it was not a bad guess. Somebody at CBS marketwatch has now lost a dime?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next